Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson B Watts

Showing results (101-110 of 179) with videos related to

Pageof 18
Sort By:
Archives of Osteoporosis|March 23, 2018
Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal womenAkeem A Yusuf, Steven R Cummings, Nelson B Watts, et al.
JBMR Plus|December 18, 2019
Do Additional Clinical Risk Factors Improve the Performance of Fracture Risk Assessment Tool (FRAX) Among Postmenopausal Women? Findings From the Women's Health Initiative Observational Study and Clinical TrialsCarolyn J Crandall, Joseph Larson, Jane A Cauley, et al.
The Journal of Clinical Endocrinology and Metabolism|January 25, 2007
Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosisPierre D Delmas, Bernard Vrijens, Richard Eastell, et al.
Southern Medical Journal|November 22, 2005
Review of treatment modalities for postmenopausal osteoporosisRonald C Hamdy, Charles H Chesnut, Margery L Gass, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosteroneJohn K Amory, Nelson B Watts, Kirk A Easley, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|May 30, 2006
Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD Official PositionsWilliam D Leslie, Robert A Adler, Ghada El-Hajj Fuleihan, et al.
Archives of Internal Medicine|April 28, 2004
A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal womenIan R Reid, Richard Eastell, Ignac Fogelman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 3, 2009
Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosisPierre D Delmas, Francoise Munoz, Dennis M Black, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 21, 2015
Urinary Tract Stones and Osteoporosis: Findings From the Women's Health InitiativeLaura D Carbone, Kathleen M Hovey, Christopher A Andrews, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 5, 2013
Skeletal health in long-duration astronauts: nature, assessment, and management recommendations from the NASA Bone SummitEric S Orwoll, Robert A Adler, Shreyasee Amin, et al.
Pageof 18

Showing results (101-110 of 179) with videos related to

Sort By:
Pageof 18
Archives of Osteoporosis|March 23, 2018
Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal womenAkeem A Yusuf, Steven R Cummings, Nelson B Watts, et al.
JBMR Plus|December 18, 2019
Do Additional Clinical Risk Factors Improve the Performance of Fracture Risk Assessment Tool (FRAX) Among Postmenopausal Women? Findings From the Women's Health Initiative Observational Study and Clinical TrialsCarolyn J Crandall, Joseph Larson, Jane A Cauley, et al.
The Journal of Clinical Endocrinology and Metabolism|January 25, 2007
Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosisPierre D Delmas, Bernard Vrijens, Richard Eastell, et al.
Southern Medical Journal|November 22, 2005
Review of treatment modalities for postmenopausal osteoporosisRonald C Hamdy, Charles H Chesnut, Margery L Gass, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosteroneJohn K Amory, Nelson B Watts, Kirk A Easley, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|May 30, 2006
Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD Official PositionsWilliam D Leslie, Robert A Adler, Ghada El-Hajj Fuleihan, et al.
Archives of Internal Medicine|April 28, 2004
A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal womenIan R Reid, Richard Eastell, Ignac Fogelman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 3, 2009
Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosisPierre D Delmas, Francoise Munoz, Dennis M Black, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 21, 2015
Urinary Tract Stones and Osteoporosis: Findings From the Women's Health InitiativeLaura D Carbone, Kathleen M Hovey, Christopher A Andrews, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 5, 2013
Skeletal health in long-duration astronauts: nature, assessment, and management recommendations from the NASA Bone SummitEric S Orwoll, Robert A Adler, Shreyasee Amin, et al.
Pageof 18